Novabay Pharmaceuticals, INC Schedule 13G passive stakes
Filed when an investor crosses five percent without intending to seek control — the passive counterpart to a 13D.
Tether Global Investments Fund and Giancarlo Devasini have filed a Schedule 13G disclosing a 9.99% beneficial ownership stake in Stablecoin Development Corp.
Poplar Point Capital Management and its affiliates have disclosed a significant 16.71% beneficial ownership stake in NovaBay Pharmaceuticals, Inc., holding 971,654 shares of common stock.
SCHEDULE 13G/A: Poplar Point Capital Management Discloses 12.7% Passive Stake in NovaBay Pharmaceuticals
Poplar Point Capital Management LLC and its affiliates have disclosed a 12.7% passive beneficial ownership stake in NovaBay Pharmaceuticals, Inc., as reported in an amended Schedule 13G filing.
Poplar Point Capital Management LLC and its affiliates have disclosed a passive beneficial ownership of 7.7% in NovaBay Pharmaceuticals, Inc. common stock.